SCHEMBL6865036

SCHEMBL6865036

O=Cc1ccc(-c2nn(Cc3ccccc3)c3ncncc23)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 9/20 0.43
LMNA P02545 7/20 0.42
ALDH1A1 P00352 6/20 0.42
CYP2C9 P11712 6/20 0.42
CYP2C19 P33261 6/20 0.42
CYP3A4 P08684 5/20 0.42
CYP1A2 P05177 5/20 0.42
MAPK1 P28482 3/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
CYP2D6 P10635 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
GMNN O75496 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867276 0.81 PDE5A (0.65) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL8507390 0.80 CYP2C9 (0.36) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL3072072 0.79 PDE5A (0.67) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL6865260 0.78 ADORA2A (0.54) LMNAALDH1A1HSD17B10SMN1; SMN2TSHR
SCHEMBL5334275 0.74 PDE5A (0.57) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL3068514 0.72 PDE5A (0.70) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL3076502 0.71 PDE5A (0.56) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL3081242 0.69 PDE5A (0.53) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL3064866 0.68 PDE5A (0.58) PDE5ALMNAALDH1A1CYP2C9CYP2C19
SCHEMBL3076227 0.67 PDE5A (0.51) PDE5ALMNAALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944631-B1 NOVEL SUBSTITUTED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CARDIOCIRCULATORY DISEASES BAYER HEALTHCARE AG (DE) 2004-02-18 EP disclosed
US-6451805-B1 Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 US disclosed